COCETTA, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 3.891
AS - Asia 2.388
EU - Europa 1.941
SA - Sud America 551
AF - Africa 450
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 18
Totale 9.282
Nazione #
US - Stati Uniti d'America 3.605
SG - Singapore 942
IT - Italia 783
CN - Cina 435
BR - Brasile 367
HK - Hong Kong 277
VN - Vietnam 177
PL - Polonia 130
DE - Germania 125
SE - Svezia 109
GB - Regno Unito 83
FI - Finlandia 79
UA - Ucraina 58
FR - Francia 56
NL - Olanda 56
IN - India 54
RU - Federazione Russa 45
CA - Canada 43
MX - Messico 42
TR - Turchia 34
AR - Argentina 33
IR - Iran 32
EC - Ecuador 30
CZ - Repubblica Ceca 29
ID - Indonesia 29
JP - Giappone 27
ZA - Sudafrica 27
AT - Austria 26
CH - Svizzera 25
ES - Italia 25
PH - Filippine 24
MA - Marocco 22
VE - Venezuela 20
AE - Emirati Arabi Uniti 19
HR - Croazia 19
AZ - Azerbaigian 18
IE - Irlanda 18
IQ - Iraq 18
AU - Australia 17
RS - Serbia 17
AO - Angola 16
BF - Burkina Faso 16
BZ - Belize 16
CM - Camerun 16
CY - Cipro 16
DZ - Algeria 16
GM - Gambi 16
IL - Israele 16
NP - Nepal 16
PY - Paraguay 16
TJ - Tagikistan 16
UY - Uruguay 16
AL - Albania 15
BD - Bangladesh 15
IS - Islanda 15
JM - Giamaica 15
LU - Lussemburgo 15
PE - Perù 15
BA - Bosnia-Erzegovina 14
BJ - Benin 14
BY - Bielorussia 14
CL - Cile 14
CO - Colombia 14
EE - Estonia 14
GT - Guatemala 14
JO - Giordania 14
KR - Corea 14
MY - Malesia 14
RE - Reunion 14
SI - Slovenia 14
TH - Thailandia 14
TT - Trinidad e Tobago 14
UZ - Uzbekistan 14
CU - Cuba 13
GF - Guiana Francese 13
PT - Portogallo 13
RO - Romania 13
SD - Sudan 13
BB - Barbados 12
BO - Bolivia 12
CR - Costa Rica 12
DO - Repubblica Dominicana 12
GN - Guinea 12
KG - Kirghizistan 12
MU - Mauritius 12
MW - Malawi 12
NI - Nicaragua 12
NO - Norvegia 12
PS - Palestinian Territory 12
SA - Arabia Saudita 12
SN - Senegal 12
SO - Somalia 12
TZ - Tanzania 12
XK - ???statistics.table.value.countryCode.XK??? 12
AM - Armenia 11
BE - Belgio 11
BS - Bahamas 11
ET - Etiopia 11
GE - Georgia 11
GH - Ghana 11
Totale 8.790
Città #
Ashburn 525
Singapore 487
Fairfield 291
Hong Kong 264
Padova 234
Chandler 222
Beijing 176
Santa Clara 171
Woodbridge 147
Cambridge 145
Ann Arbor 133
Seattle 126
Houston 119
San Jose 110
Boardman 104
Wilmington 104
Bytom 87
Los Angeles 84
Medford 68
Princeton 68
Ho Chi Minh City 66
New York 62
Milan 59
Munich 58
Helsinki 47
Des Moines 44
San Diego 36
Hanoi 34
Warsaw 31
Malo 26
Nanjing 26
Rome 26
São Paulo 26
Denver 22
Buffalo 21
Mexico City 21
Roxbury 21
Tokyo 21
Brooklyn 20
Montreal 20
Poplar 20
Chicago 19
Stockholm 19
Redondo Beach 18
Amsterdam 17
Baku 17
Dallas 17
Johannesburg 17
Turku 17
Phoenix 16
Atlanta 15
Dublin 15
Palermo 15
Zagreb 15
Amman 14
Montevideo 14
Orem 14
Chennai 13
Dushanbe 13
Manchester 13
Rio de Janeiro 13
Tashkent 13
Washington 13
Boston 12
Cagliari 12
Conakry 12
Dakar 12
Falkenstein 12
Havana 12
Managua 12
Ouagadougou 12
Reykjavik 12
Tallinn 12
Banjul 11
Belgrade 11
Belo Horizonte 11
Bridgetown 11
Cotonou 11
Naples 11
Niamey 11
Parma 11
Phnom Penh 11
Quito 11
The Dalles 11
Vienna 11
Yerevan 11
Abidjan 10
Accra 10
Andorra la Vella 10
Ankara 10
Arezzo 10
Bishkek 10
Castries 10
Catania 10
Guatemala City 10
Libreville 10
Limassol 10
London 10
Luanda 10
Minsk 10
Totale 5.112
Nome #
Anti-senescence activity of Salvia haenkei on skin cellular model identified by integrated senescence-screening assay 249
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 248
Mitochondrial Involvement in Cisplatin Resistance 231
Peculiar combinations of individually non-pathogenic missense mitochondrial DNA variants cause low penetrance Leber’s hereditary optic neuropathy 207
A fixed combination of probiotics and herbal extracts attenuates intestinal barrier dysfunction from inflammatory stress in an in vitro model using Caco-2 cells. 206
Further assessment of Salvia haenkei as an innovative strategy to counteract skin photo-aging and restore the barrier integrity 201
Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay 197
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 187
Polyoxometalates-peptides conjugates for cancer cell targeting: a structural investigation 178
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 178
Protective effects of ψ taraxasterol 3-O-myristate and arnidiol 3-O-myristate isolated from Calendula officinalis on epithelial intestinal barrier 167
In Vitro Cultured Melissa officinalis Cells as Effective Ingredient to Protect Skin Against Oxidative Stress, Blue Light, and Infrared Irradiations Damages 166
Interaction between Mitochondrial DNA Variants and Mitochondria/Endoplasmic Reticulum Contact Sites: A Perspective Review 163
Lindqvist polyoxovanadate-peptides conjugates for cancer cell targeting 163
Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress 162
Anti-inflammatory activity of a fixed combination of probiotics and herbal extract in an in-vitro model of intestinal inflammation by stimulating Caco-2 cells with LPS-conditioned THP-1 cells medium 151
Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression 151
Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2 150
New insights in cisplatin-resistance: role of metabolic reprogramming in cancer cells 147
Milk kefir enriched with inulin-grafted seed extract from white wine pomace: chemical characterisation, antioxidant profile and in vitro gastrointestinal digestion 147
Clinical evidence of interaction between nutraceutical supplementation and platinum-based chemotherapy 145
Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy 143
Anti-ageing activity of Salvia haenkei in an in vitro epidermal model 142
Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH) 134
Study of metabolic reprogramming and identification of new pharmacological targets in chemotherapy resistance 132
Overcome cisplatin -resistance by targetin glucose-6-phosphate dehydrogenase with the combination of liposomal cisplatin and 6-amino nicotinamide 128
Retrospective Analysis of the Effect of Postmenopausal Women Medications on SARS-CoV-2 Infection Progression 126
The SARS-CoV-2 spike protein binds and modulates estrogen receptors 123
Plumbagin Induces Cell Cycle Arrest and Apoptosis in A431 Cisplatin-Resistant Cancer Cells 121
Anti-senescence activity of Salvia Haenkei on a skin cellular model 119
Novel Adenosine Triphosphate-Based Nutraceutical Formulation to Prevent Non-Steroidal Anti-Inflammatory Drug Enteric Cell Toxicity: Preliminary In Vitro Evidence 119
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy 115
Silybin as a new tool to counteract doxorubicin resistance by targeting glucose uptake 112
Mitochondrial phenotyping of doxorubicin-resistant osteosarcoma cells 111
Metabolic reprogramming in triple negative breast cancer cells: role of glutamine and glucose in cisplatin resistance 110
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives 109
Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells 108
UN NAFTOCHINONE ESTRATTO DALLA PIANTA PLUMBAGO ZEYLANICA L. INDUCE MORTE CELLULARE DELLE CELLULE RESISTENTI AL CISPLATINO 108
Silybin, curcumin and quercetin as metabolic modulators in human resistant cancer cells 108
Targeting glucose-6-phosphate dehydrogenase by 6-amino nicotinamide in combination with liposomal cisplatin as a strategy to sensitize ovarian resistant cancer cells 107
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 106
Role of mitochondria in cisplatin-resistance phenomena 105
Imbalance of mitochondrial "shaping proteins" and cisplatin resistance 104
Natural compounds as metabolic modulators in resistant cancer cells models 103
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 103
VALIDAZIONE IN VITRO DI UNA COMBINAZIONE DI SERENOA REPENS E URTICA DIOICA PER LA TERAPIA DELL'IPERPLASIA PROSTATICA BENIGNA 103
Potential effect of Salvia Haenkey on in vitro wound healing 102
Maintenance of intestinal epithelial barrier integrity by a combination of probiotics, herbal extract, and vitamins 100
Mitochondrial alterations involved in cisplatin resistance phenomena 100
Mitophagic/autophagic inhibitors as new strategy to overcome cisplatin resistance in cancer 100
CHARACTERIZATION OF MITOCHONDRIAL METABOLISM OF DOXORUBICIN-RESISTANT OSTEOSARCOMA CELLS 99
Mitochondrial remodeling involved in cisplatin resistance 99
Mitochondria as cisplatin targets: new apporach to counteract resistance mechanism 99
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses CisplatinResistance: new pharmacological approach using Cisplatin liposome and 6-amino nicotinamide combination 99
Links between cancer metabolism and cisplatin resistance 99
IDENTIFICAZIONE DI ESTRATTI NATURALI CON PROMETTENTE APPLICAZIONE IN FITOCOSMESI 99
Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal Extracts in an In Vitro Model of Intestinal Epithelial Barrier Dysfunction 96
Lipid-metabolic reprogramming in ovarian carcinoma cell lines resistant to cisplatin 93
GLUTAMINE METABOLISM IN TRIPLE-NEGATIVE BREAST CANCER AND ITS ROLE IN CISPLATIN RESISTANCE 91
Curcumin and Cisplatin as new chemotherapeutic compounds in order to overcome cisplatin resistance 90
VALUTAZIONE DELL’ATTIVITA’ ANTI-INVECCHIAMENTO DELL’ESTRATTO AS PER APPLICAZIONE FITOCOSMETICA 89
Natural polyphenol sensitize cancer cells to cisplatin effect on cell cycle 88
Cannabis Sativa modulates epithelial permeability in an in vitro intestinal inflammation model 88
SILYBIN: A NATURAL COMPOUND ABLE TO OVERCOME DOXORUBICIN RESISTANCE PHENOMENA 88
Natural compounds as metabolic modulators in resistant cancer models 84
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 82
Calu-3 cells as in vitro model of bronchial epithelium for pharmacological studies of natural compounds 81
Targeting glucose-6-phosphate dehydrogenase with a combination of liposomal cisplatin and 6-amino nicotinamide as new strategy to overcome cisplatin-resistance 81
Silybin chemosensitize doxorubicin-resistant cells by targeting GLUT1 79
Antioxidant and anti-inflammatory activities of Cannabis Sativa in epithelial intestinal cell 72
Natural compounds as possible modulators of lipid metabolism in cisplatin-resistant cancer cells 72
Cannabis Sativa L. modulates epithelial permeability in an in vitro intestinal inflammation model 72
Natural compounds as metabolic modulators in resistant cancer cell models 68
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 66
Natural polyphenols as chemosensitizer: studies in resistant cancer cells. 59
Silybin glycolysis inhibitor as promising agent in chemotherapy 54
Natural polyphenols chemosensitize cisplatin-resistant cells through cell cycle modulation 54
Sviluppo di un decongestionante nasale a base fitoterapica 51
Totale 9.387
Categoria #
all - tutte 29.195
article - articoli 16.568
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 290
Totale 46.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021356 0 0 0 0 0 0 65 40 65 68 84 34
2021/2022667 17 117 42 22 23 69 27 39 80 16 29 186
2022/2023598 129 46 21 36 120 59 6 32 80 3 47 19
2023/2024554 24 59 60 45 42 76 49 70 16 13 39 61
2024/20252.078 117 102 97 89 319 58 129 203 111 82 304 467
2025/20264.138 415 586 792 1.091 771 313 170 0 0 0 0 0
Totale 9.387